{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:31:21Z","timestamp":1773063081854,"version":"3.50.1"},"reference-count":24,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.2217\/imt-2018-0197","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T11:41:29Z","timestamp":1561462889000},"page":"937-944","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["A Review of Kallikrein Inhibitor Lanadelumab in Hereditary Angioedema"],"prefix":"10.1080","volume":"11","author":[{"given":"Gloria","family":"Hwang","sequence":"first","affiliation":[{"name":"The Pennsylvania State University College of Medicine, Penn State University, 500 University Drive, Hershey, PA17033, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansh","family":"Johri","sequence":"additional","affiliation":[{"name":"The Pennsylvania State University College of Medicine, Penn State University, 500 University Drive, Hershey, PA17033, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Ng","sequence":"additional","affiliation":[{"name":"The Pennsylvania State University College of Medicine, Penn State University, 500 University Drive, Hershey, PA17033, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Craig","sequence":"additional","affiliation":[{"name":"Allergy, Asthma & Immunology, the Pennsylvania State University, College of Medicine, Department of Medicine and Pediatrics, 500 University Drive, Hershey, PA17033, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0803977"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.055"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/509899"},{"key":"e_1_3_3_6_1","unstructured":"US Hereditary Angioedema Association - The Disease. https:\/\/www.haea.org\/HAEdisease.php"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.01.007"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905079"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175899"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605767"},{"key":"e_1_3_3_11_1","first-page":"1","article-title":"Prophylaxis for hereditary angioedema with lanadelumab and C1 inhibitors: effectiveness and value","author":"Lin GA","year":"2018","unstructured":"Lin GA , AgboolaF , ChapmanRet al. Prophylaxis for hereditary angioedema with lanadelumab and C1 inhibitors: effectiveness and value. Institute for Clinical and Economic Review.1\u2013136 (2018).","journal-title":"Institute for Clinical and Economic Review."},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70095-2"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-017-0172-9"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613627"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","unstructured":"Kaplon H ReichertJM. Antibodies to watch. MAbs11 219\u2013238 (2019).","DOI":"10.1080\/19420862.2018.1556465"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.569061"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.05.028"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.16773"},{"key":"e_1_3_3_19_1","unstructured":"Long-term Safety and Efficacy Study of DX-2930 (SHP643) to prevent acute angioedema attacks in patients with Type I and Type II HAE (2016). clinicaltrials.gov"},{"key":"e_1_3_3_20_1","unstructured":"Efficacy and Safety Study of DX-2930 to prevent acute angioedema attacks in patients With Type I and Type II HAE (2018). clinicaltrials.gov"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.08.040"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805538"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.04.018"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-011-0203-x"},{"key":"e_1_3_3_25_1","unstructured":"Efficacy and Safety Study of DX-2930 to prevent acute angioedema attacks in patients with Type I and Type II HAE (2018). clinicaltrials.gov"},{"issue":"14","key":"e_1_3_3_26_1","first-page":"S299","article-title":"Current and emerging therapies to prevent hereditary angioedema attacks","volume":"24","author":"Lumry W.R","year":"2018","unstructured":"Lumry W.R . Current and emerging therapies to prevent hereditary angioedema attacks. Am. J. Manag. Care24(14), S299\u2013S307 (2018).","journal-title":"Am. J. Manag. Care"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2018-0197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:33:55Z","timestamp":1715952835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2018-0197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.2217\/imt-2018-0197"],"URL":"https:\/\/doi.org\/10.2217\/imt-2018-0197","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}